Brief: Turk Ilac Ve Serum Says It Gets FDA Approval For Turkfleks Iv Serums, Authorised For Sale In U.S.
April 3 (Reuters) - TURK İLAÇ VE SERUM SANAYİ TRILC.IS: TURK İLAÇ VE SERUM GETS FDA (FOOD AND DRUG ADMINISTRATION) FOR ITS TURKFLEKS PARENTERAL SOLUTIONS (SERUMS) SAYS ITS TURKFLEKS RANGE OF PRODUCTS ARE AUTHORISED FOR SALE IN U.S. Source text for Workspace: nIKAbgnKhB Further company coverage: TRILC.IS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Turk Ilac ve Serum Sanayi AS
See all newsTurk Ilac slides after debt restructuring entry
Turk Ilac says it granted 3-month interim protection for restructuring process
Brief: Turk Ilac Says It Signs $5.0 Mln Contract With Turkmenistan Health Ministry
Brief: Turk Ilac Says It Wins Turkish State Supply Office Tender Valued 209.6 Mln Lira + VAT
Brief: Turk Ilac Says It Signs Distribution Agreement With Aversi LLC